Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORCHIDEE: Everolimus in mRCC
NCT02338570Phase 4Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jul 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in renal cell carcinoma (RCC), sponsored by Mario Negri Institute for Pharmacological Research. Started Jul 2015; status: terminated.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT02338570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338570.